#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Inclusion body myositis Hodgkin's disease recurrent Retinal dystrophy Neuroblastoma Stress cardiomyopathy Turner's syndrome Postprandial hypoglycaemia Duchenne muscular dystrophy Rosai-Dorfman syndrome Polymyositis Salivary gland cancer Thymic carcinoma Fungal infection White matter lesion Brain stem glioma More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Basic Information Hereditary ataxia – Treatment Osteosarcoma – Trials in Disease Cystic fibrosis lung – Diagnostics Turner’s syndrome – Diagnostics Focal segmental glomerulosclerosis – Basic Information Pemphigoid Alport’s syndrome – Life with Disease Piriformis syndrome – Treatment Cystic fibrosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dipyridamole RO7837195 Eribulin Tiotropium Bromide Blu-222 Pseudoephedrine Hydrochloride Belimumab CYCLIZINE HYDROCHLORIDE DUVELISIB Ampicillin Sodium 18F-Fludarabine PUCOTENLIMAB Tranexamic Acid Ep0042 Interferon Alfa Adalimumab Indocyanine Green Cefiderocol Lactulose Lt3001 More therapies…

    Learn about Your Condition

    Osteosarcoma recurrent Urticaria chronic Malignant mast cell neoplasm Obstructive airways disorder Conjunctivitis Primary hyperaldosteronism Acute myocardial infarction B-cell type acute leukaemia Pneumonia chlamydial Haemofiltration Dupuytren's contracture Bone marrow disorder Systemic sclerosis pulmonary Breast cancer stage IV Diabetic gastroparesis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Patient‑chosen treatment vs routine surgery for adult uncomplicated acute appendicitis: trial of amoxicillin‑clavulanic acid versus appendectomy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Amoxicillin Sodium
    • Clavulanic Acid
    France

  • Effect of Stopping Long‑Term Azithromycin in Stable Non‑Cystic Fibrosis Bronchiectasis Patients: A Randomized Controlled Trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Azithromycin
    France

  • Feasibility Study of Fluorescence Bronchoscopy Using bevacizumab-800CW in Patients with Suspected Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Bevacizumab
    The Netherlands

  • Fluoroethyltyrosine F-18 PET Scan for Adults with Suspected Functional Pituitary Adenoma and Unclear MRI Results

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Pituitary tumour benign
    Investigated Drugs:
    • Fluoroethyltyrosine F-18
    France

  • Anakinra for patients with myeloproliferative neoplasms resistant to cytoreductive therapy: a study to improve treatment response

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Myeloproliferative neoplasm
    Investigated Drugs:
    • Anakinra
    France

  • Study of Cemiplimab, Platinum and Gemcitabine in Treatment‑Naïve Patients with Advanced Squamous Non‑Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of lung
    Investigated Drugs:
    • Cemiplimab
    Italy
Previous Page
1 … 683 684 685 686 687 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!